期刊文献+

经皮冠状动脉成形术后对比剂肾病的研究进展 被引量:14

下载PDF
导出
摘要 近年来,随着经皮冠状动脉成形术(PCI)的迅猛开展及对比剂的广泛应用,对比剂肾病(CIN)的发病率显著升高,成为继手术及药物之后院内获得性肾损伤的第3大原因,约占11%。CIN一旦发生,患者的住院时间及费用明显增多,心血管不良事件及病死率也将显著增加,
机构地区 天津市胸科医院
出处 《山东医药》 CAS 2012年第8期97-99,共3页 Shandong Medical Journal
基金 天津市卫生局科技基金重点攻关项目(10KG122)
  • 相关文献

参考文献11

  • 1Toprak O.Risk markers for contrast induced nephropathy[J].Am J Med Sci,2007,334(4):283-290.
  • 2Rihal CS,Textor SC,Grill DE,et al.Incidence and prognostic im-portance of acute renal failure after percutaneous coronary interven-tion[J].Circulation,2002,105(19):2259-2264.
  • 3Lindsay J,Apple S,Pinnow EE,et al.Percutaneous coronary inter-vention associated nephro-pathy foreshadows increased risk of lateadverse events in patients with normal baseline serum creatinine[J].Catheter Cardiovasc Interv,2003,59(3):338-343.
  • 4McCullough PA,Wolyn R,Rocher LL,et al.Acute renal failureafter coronary intervention:incidence,risk factors,and relationshipto mortality[J].Am J Med,1997,103(5):368-375.
  • 5Bartholomew BA,Harjai KJ,Dukkipati S,et al.Impact of ne-phropathy after percutaneous coronary intervention and a method forrisk stratification[J].Am J Cardiol,2004,93(12):1515-1519.
  • 6Mehran R,Aymong E,Nikolsky E,et al.A simple risk score forprediction of CIN after percutaneous coronary intervention:Develop-men and innitial Validation[J].J Am Coll Cardiol,2004,44(7):1393-1399.
  • 7Maioli M,Toso A,Gallopin M,et al.Preprocedural score for risk ofcontrast-induced nephro-pathy in elective coronary angiography andintervention[J].J Cardiovasc Med,2010,11(6):444-449.
  • 8Bachorzewska-Gajewska H,Malyszko J,Sitniewska E,et al.Couldneutrophil gelatinase asso-ciated lipocalin and cystatin C predict thedevelopment of contrast induced nephropathy after percutaneous cor-onary interventions in patients with stable angina and normal serumcreate-nine values[J].Kidney Blood Press Res,2007,30(6):408-4015.
  • 9Hirsch R,Dent C,Pfriem H,et al.NGAL is an early predictive bi-omarker of contrast induced nephropathy in children[J].PediatrNephrol,2007,22(12):2089-2095.
  • 10Jaffery Z,Verma A,White CJ,et al.A randomized trial of intra-venous N-acetylcysteine to prevent contrast induced nephropathy inacute coronary syndromes[J].Catheter Cardiovasc Interv,2011,335(3):201-206.

同被引文献119

  • 1侯湘岭,刘慧,王伟红,陈伟,付晨阳.不同水化方法对冠状动脉介入术后造影剂肾病的临床观察[J].中华临床医师杂志(电子版),2011,5(13):3968-3970. 被引量:18
  • 2胡洁之,翁志蓬,刘杰明,潘石宏.低渗非离子型造影剂碘普罗胺的肾脏安全性评价[J].实用医技杂志,2005,12(04B):985-986. 被引量:6
  • 3Nash K,Hafeez A, Hou S. Hospital-acquired renal insuf-ficiency[J]. Am J Kidney Dis, 2002,39(5) : 930.
  • 4Thomsen HS. How to avoid CIN : guidelines from the Eu-ropean Society of Urogenital Radiology [J]. Nephrol DialTransplant,2005,20(Suppl 1):i18.
  • 5Trivedi HS,Moore H, Nasr S,et al. A randomized pros-pective trial to assess the role of saline hydration on thedevelopment of contrast nephrotoxicity [J]. Nephron ClinPract,2003,93(1):C29.
  • 6Chronopoulos A, Rosner MH,Qruz DN, et al. Acute kid-ney injury in the elderly : a review[J]. Contrib Nephrol,2010,165:315.
  • 7Rihal CS,Textor SC,Grill DE,et al. Incidence and prog-nostic importance of acute renal failure after percutaneouscoronary intervention!^]. Circulation, 2002,105 (19):2 259.
  • 8Maeder M,Klein M, Fehr T,et al. Contrast nephropa-thy :review focusing on prevention[J]. J Am Coll Cardiol,2004,44(9):1 763.
  • 9Tumlin J, Stacul F,Adam A, et al. Pathophysiology ofcontrast-induced nephropathy [J]. Am J Cardiol, 2006,98(6A):14K.
  • 10Toprak O. Risk markers for contrast-induced nephropathy[J]. Am J Med Sci, 2007,334(4):283.

引证文献14

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部